ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ABBV AbbVie Inc

163.6196
-0.9404 (-0.57%)
22 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
AbbVie Inc ABBV NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.9404 -0.57% 163.6196 08:13:25
개장가 저가 고가 종가 전일 종가
165.29 162.50 165.705 162.93 164.56
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/05/202420:30PRNUSAbbVie Presents New Data Supporting Leading Gastroenterology..
13/05/202421:39PRNUSAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration..
09/05/202406:00EDGAR2Form 8-K/A - Current report: [Amend]
08/05/202421:00PRNCAQULIPTA(MC) (atogépant) est maintenant approuvé par Santé..
08/05/202409:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/05/202421:00PRNUSAbbVie to Present at the Bank of America Securities..
26/04/202420:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/04/202420:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/04/202421:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/04/202421:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/04/202421:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/04/202420:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/04/202421:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/04/202421:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/04/202421:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/04/202420:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/03/202420:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
26/03/202400:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/03/202421:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/03/202421:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
23/03/202404:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/03/202421:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07/03/202422:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06/03/202422:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
06/03/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202402:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05/03/202422:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/03/202421:00PRNUSDragonfly has Received Milestone Payment Following Dosing of..
02/03/202409:53EDGAR2Form 144 - Report of proposed sale of securities
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:20EDGAR2Form 144 - Report of proposed sale of securities
01/03/202408:06EDGAR2Form 144 - Report of proposed sale of securities
01/03/202407:33EDGAR2Form 144 - Report of proposed sale of securities
01/03/202406:04EDGAR2Form 144 - Report of proposed sale of securities
28/02/202414:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
28/02/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202422:00GLOBEHealis Therapeutics' asset CKDB-501A shares Phase III..
27/02/202421:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..

최근 히스토리

Delayed Upgrade Clock